TY - JOUR
T1 - Correction to
T2 - A personal sensing technology enabled service versus a digital psychoeducation control for primary care patients with depression and anxiety: a pilot randomized controlled trial (BMC Psychiatry, (2024), 24, 1, (828), 10.1186/s12888-024-06284-z)
AU - Stiles-Shields, Colleen
AU - Reyes, Karen M.
AU - Lakhtakia, Tanvi
AU - Smith, Shannon R.
AU - Barnas, Olga E.
AU - Gray, Elizabeth L.
AU - Krause, Charles J.
AU - Kruzan, Kaylee P.
AU - Kwasny, Mary J.
AU - Mir, Zara
AU - Panjwani, Sameer
AU - Rothschild, Steven K.
AU - Sánchez-Johnsen, Lisa
AU - Winquist, Nathan W.
AU - Lattie, Emily G.
AU - Allen, Nicholas B.
AU - Reddy, Madhu
AU - Mohr, David C.
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2025/12/1
Y1 - 2025/12/1
N2 - Following the publication of the original article [1], the authors identified an error in the competing interests statement. The correct statement is given below. Competing interests David C. Mohr, PhD has accepted honoraria and consulting fees from Boehringer-Ingelheim, Optum Behavioral Health, Centerstone Research Institute, Woebot Health, and has an ownership interest in Adaptive Health, Inc., which is unrelated to this paper. Emily G. Lattie, PhD is employed by Lyra Health and Lyra Clinical Associates, receives income from Lyra Health and Lyra Clinical Associates, and has been granted equity in Lyra Health. Nicholas B. Allen has an equity interest in, and receives salary from, Ksana Health Inc., who have developed and commercialized the Vira platform. Madhu Reddy, PhD has accepted honoraria from Boehringer-Ingelheim. The original article [1] has been corrected.
AB - Following the publication of the original article [1], the authors identified an error in the competing interests statement. The correct statement is given below. Competing interests David C. Mohr, PhD has accepted honoraria and consulting fees from Boehringer-Ingelheim, Optum Behavioral Health, Centerstone Research Institute, Woebot Health, and has an ownership interest in Adaptive Health, Inc., which is unrelated to this paper. Emily G. Lattie, PhD is employed by Lyra Health and Lyra Clinical Associates, receives income from Lyra Health and Lyra Clinical Associates, and has been granted equity in Lyra Health. Nicholas B. Allen has an equity interest in, and receives salary from, Ksana Health Inc., who have developed and commercialized the Vira platform. Madhu Reddy, PhD has accepted honoraria from Boehringer-Ingelheim. The original article [1] has been corrected.
UR - http://www.scopus.com/inward/record.url?scp=85213950337&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85213950337&partnerID=8YFLogxK
U2 - 10.1186/s12888-024-06403-w
DO - 10.1186/s12888-024-06403-w
M3 - Comment/debate
C2 - 39748325
AN - SCOPUS:85213950337
SN - 1471-244X
VL - 25
JO - BMC Psychiatry
JF - BMC Psychiatry
IS - 1
M1 - 4
ER -